Pàgina inicial > Resultats de la cerca: CAR-T cell
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Documents de recerca, 1 registres trobats
Articles 1 registres trobats  
1.
16 p, 3.4 MB CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors / Dragon, Anna Christina (Hannover Medical School) ; Beermann, Luca Marie (Hannover Medical School) ; Umland, Melina (Hannover Medical School) ; Bonifacius, Agnes (Hannover Medical School) ; Malinconico, Chiara (Hannover Medical School) ; Ruhl, Louisa (Hannover Medical School) ; Kehler, Patrik (Glycotope GmbH) ; Gellert, Johanna (Glycotope GmbH) ; Weiß, Lisa (Glycotope GmbH) ; Mayer-Hain, Sarah (Glycotope GmbH) ; Zimmermann, Katharina (Hannover Medical School) ; Riese, Sebastian (Hannover Medical School) ; Thol, F. (Department of Hematology. Hannover Medical School) ; Beutel, Gernot (Hannover Medical School) ; Maecker-Kolhoff, B. (Department of Pediatric Hematology and Oncology. Hannover Medical School) ; Yamamoto, Felicitas (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Blasczyk, Rainer (Hannover Medical School) ; Schambach, Axel (Hannover Medical School) ; Hust, Michael (Department of Medical Biotechnology. Technical University of Braunschweig) ; Hudecek, Michael (Department of Internal Medicine II. University Hospital of Würzburg) ; Eiz-Vesper, Britta (Hannover Medical School) ; Universitat Autònoma de Barcelona
Introduction: Chimeric antigen receptor-engineered T cells (CAR-Ts) are investigated in various clinical trials for the treatment of cancer entities beyond hematologic malignancies. A major hurdle is the identification of a target antigen with high expression on the tumor but no expression on healthy cells, since "on-target/off-tumor" cytotoxicity is usually intolerable. [...]
2023 - 10.3389/fimmu.2023.1219165
Frontiers in immunology, Vol. 14 (2023) , p. 1219165  
Registre complet - Creative Commons

Documents de recerca 1 registres trobats  
1.
1 p, 2.4 MB CRISPR technology and its application in cancer / Fagoaga Eugui, Maider ; Dunach, Mireia, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
CRISPR is a revolutionary genome-editing technology derived from the adaptive immune system of prokaryotes, which integrate short fragments of foreign nucleic acids in their genome in a specific manner and this serves as a vaccination card or cellular memory of past invaders. [...]
2019-05-31
Grau en Bioquímica [814]  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem